Cubresa is pleased to announce that it has signed a global Master Interface Agreement with Siemens Healthineers. The agreement is a broad contract designed to support development efforts and ...
Cubresa is pleased to announce that it has signed a global Master Interface Agreement with Siemens Healthineers. The agreement is a broad contract ...
Cubresa is pleased to announce that it has signed a global Master Interface Agreement with Siemens Healthineers. The agreement is a broad contract designed to support development efforts and ...
Neurodiagnostics Market Research Report In 2020, the global neurodiagnostics market was valued at $6,530 million and is projected to reach ...
GlobalData on MSN21h
Radiopharm’s imaging molecule hits mark in observational trialThe company’s RAD 101 imaging molecule identified brain tumours in all 12 treatment-naïve patients in a proof-of-concept ...
Successful detection of brain metastases using RAD 101 (18F-Pivalate) in a novel multiparametric imaging methodology (PET-mpMRI) study across 22 patients.All brain metastases, regardless of whether th ...
Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor ...
Researchers have developed a method that leverages artificial intelligence to ensure accurate heart scans without added radiation or cost.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback